4.7 Article

PDGF-BB Carried by Endothelial Cell-Derived Extracellular Vesicles Reduces Vascular Smooth Muscle Cell Apoptosis in Diabetes

期刊

DIABETES
卷 67, 期 4, 页码 704-716

出版社

AMER DIABETES ASSOC
DOI: 10.2337/db17-0371

关键词

-

资金

  1. Ministero dell'Universita e della Ricerca Scientifica
  2. Associazione Italiana per la Ricerca sul Cancro project [IG 2015.17630]

向作者/读者索取更多资源

Endothelial cell-derived extracellular vesicles (CD31EVs) constitute a new entity for therapeutic/prognostic purposes. The roles of CD31EVs as mediators of vascular smooth muscle cell (VSMC) dysfunction in type 2 diabetes (T2D) are investigated herein. We demonstrated that, unlike serum-derived extracellular vesicles in individuals without diabetes, those in individuals with diabetes (D CD31EVs) boosted apoptosis resistance of VSMCs cultured in hyperglycemic condition. Biochemical analysis revealed that this effect relies on changes in the balance between antiapoptotic and proapoptotic signals: increase of bcl-2 and decrease of bak/bax. D CD31EV cargo analysis demonstrated that D CD31EVs are enriched in membrane-bound platelet-derived growth factor-BB (mbPDGF-BB). Thus, we postulated that mbPDGF-BB transfer by D CD31EVs could account for VSMC resistance to apoptosis. By depleting CD31EVs of platelet-derived growth factor-BB (PDGF-BB) or blocking the PDGF receptor beta on VSMCs, we demonstrated that mbPDGF-BB contributes to D CD31EV-mediated bak/bax and bcl-2 levels. Moreover, we found that bak expression is under the control of PDGF-BB-mediated microRNA (miR)-296-5p expression. In fact, while PDGF-BB treatment recapitulated D CD31EV-mediated antiapoptotic program and VSMC resistance to apoptosis, PDGF-BB-depleted CD31EVs failed. D CD31EVs also increased VSMC migration and recruitment to neovessels by means of PDGF-BB. Finally, we found that VSMCs, from human atherosclerotic arteries of individuals with T2D, express low bak/bax and high bcl-2 and miR-296-5p levels. This study identifies the mbPDGF-BB in D CD31EVs as a relevant mediator of diabetes-associated VSMC resistance to apoptosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance

Cristina Bianchi, Francesco Raggi, Chiara Rossi, Simona Frontoni, Riccardo C. Bonadonna, Stefano Del Prato, Anna Solini

Summary: The study reveals that MG53 is associated with glucose tolerance, and higher levels of MG53 are related to worsened glucose regulation and impaired beta-cell function. Among individuals at high risk of T2DM, those with higher baseline MG53 levels are more likely to progress to T2DM.

DIABETES & METABOLISM (2022)

Article Immunology

P2X7 Receptor and Heart Function in a Mouse Model of Systemic Inflammation Due to High Fat Diet

Francesco Raggi, Chiara Rossi, Francesco Faita, Mariarosaria Distaso, Claudia Kusmic, Anna Solini

Summary: The study reveals the role of P2X7 receptor in regulating cardiac function and protecting the heart from inflammatory damage in obesity or type 2 diabetes. P2X7 receptor activation contributes to tissue homeostasis and preservation of organ functionality, providing a potential therapeutic target for heart failure in these conditions.

JOURNAL OF INFLAMMATION RESEARCH (2022)

Article Biochemistry & Molecular Biology

The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage

Chiara Rossi, Antonio Salvati, Mariarosaria Distaso, Daniela Campani, Francesco Raggi, Edoardo Biancalana, Domenico Trico, Maurizia Rossana Brunetto, Anna Solini

Summary: The role of inflammasomes in non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and viral-related liver disease has been investigated. The study found that P2X7R-NLRP3 and AIM2 inflammasomes play a major role in liver inflammation accompanying chronic HCV infection and metabolic damage. It also discovered the hepatic expression of IL-2 in NASH, which was previously considered a characteristic of HCV-related liver damage.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pharmacology & Pharmacy

Mechanisms of cardio-renal protection of sodium-glucose cotransporter-2 inhibitors

Martina Chiriaco, Domenico Trico, Anna Solini

Summary: SGLT2i is a drug used to treat type 2 diabetes with additional benefits for the heart and kidneys. Its mechanisms include blood pressure reduction, improvement of endothelial function, optimization of metabolism and ion exchange, reduction of inflammation and oxidative stress. These mechanisms provide solid clinical evidence for the use of SGLT2i in patients with cardiorenal syndrome.

CURRENT OPINION IN PHARMACOLOGY (2022)

Article Medicine, General & Internal

Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases

Guido Bocci, Paola Orlandi, Maria Laura Manca, Chiara Rossi, Antonio Salvati, Maurizia Rossana Brunetto, Anna Solini

Summary: This study found that circulating biomarker profiles can predict the severity of chronic liver disease of NAFLD/NASH or HCV origin. In HCV patients, there was an inverse correlation between disease stage and circulating levels of BMP-9 and VEGF-A, while in NASH/NAFLD, direct correlations between stage and BMP-9 and VEGF-A circulating levels were observed.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Synergistic effect of chronic kidney disease, neuropathy, and retinopathy on all-cause mortality in type 1 and type 2 diabetes: a 21-year longitudinal study

Luca Sacchetta, Martina Chiriaco, Lorenzo Nesti, Simone Leonetti, Giovanna Forotti, Andrea Natali, Anna Solini, Domenico Trico

Summary: This study demonstrates the long-term impact of diabetic microvascular complications (MVC) on all-cause mortality in diabetes patients and reveals the varying effects of different combinations of MVC on mortality risk.

CARDIOVASCULAR DIABETOLOGY (2022)

Article Endocrinology & Metabolism

Parameters influencing renal response to SGLT2 inhibitors and GLP1 receptor agonists in type 2 diabetes patients with preserved renal function: a comparative, prospective study

E. Biancalana, G. Petralli, F. Raggi, Mr Distaso, G. Piazza, C. Rossi, D. Trico, A. Solini

Summary: This study examined the role of patient phenotype prior to treatment in determining the kidney response to SGLT2 inhibitors and GLP1 receptor agonists in type 2 diabetes patients. The results showed that patients with a faster decline in eGFR were more likely to benefit from treatment with SGLT2 inhibitors.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Cell Biology

Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Promote Corneal Wound Repair by Regulating Inflammation and Angiogenesis

Gabriele Saccu, Valeria Menchise, Chiara Gai, Marina Bertolin, Stefano Ferrari, Cristina Giordano, Marta Manco, Walter Dastru, Emanuela Tolosano, Benedetta Bussolati, Enzo Calautti, Giovanni Camussi, Fiorella Altruda, Sharmila Fagoonee

Summary: A study found that topical application of bone-marrow-derived mesenchymal stromal/stem cell-derived extracellular vesicles (BMSC-EVs) can accelerate corneal damage repair, suggesting a promising cell-free approach for treating burns in the avascularized region of the eye.
Article Endocrinology & Metabolism

Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study

Diego Moriconi, Luca Sacchetta, Martina Chiriaco, Lorenzo Nesti, Giovanna Forotti, Andrea Natali, Anna Solini, Domenico Trico

Summary: This study evaluated the prognostic value of glomerular hyperfiltration in predicting long-term kidney-related outcomes and mortality in patients with diabetes. The analysis of 21-year longitudinal data showed that glomerular hyperfiltration is associated with worse kidney function and increased risk of mortality from cardiovascular or renal causes. Active screening of these patients is recommended for better risk stratification and treatment of subclinical kidney disease.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy Subjects

Edoardo Biancalana, Chiara Rossi, Francesco Raggi, Mariarosaria Distaso, Domenico Trico, Simona Baldi, Ele Ferrannini, Anna Solini

Summary: This study aimed to investigate the involvement of NHE3 in modulating the response to sodium glucose co-transporter-2 inhibitors in humans. The results showed that empagliflozin acutely increased urinary pH and induced a substrate shift toward lipid utilization and ketogenesis in healthy young male volunteers, without significant changes in renal NHE3 protein expression.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Endocrinology & Metabolism

MG53 does not mark cardiovascular risk and all-cause mortality in subjects with type 2 diabetes: A prospective, observational study

Cristina Bianchi, Olga Vaccaro, Mariarosaria Distaso, Laura Franzini, Francesco Raggi, Anna Solini

Summary: MG53 is not associated with cardiovascular risk profile or long-term mortality in Caucasian individuals with T2D.

DIABETES RESEARCH AND CLINICAL PRACTICE (2023)

Article Endocrinology & Metabolism

Simple proxies of insulin resistance identify obese metabolic dysfunction-associated fatty liver disease subjects with advanced liver disease

Giovanni Petralli, Antonio Salvati, Domenico Trico, Gabriele Ricco, Piero Colombatto, Maurizia Rossana Brunetto, Anna Solini

Summary: Insulin resistance is independently associated with non-invasive markers of MAFLD severity in overweight/obese individuals, and this relationship is largely mediated by hyperinsulinemia.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Review Endocrinology & Metabolism

Incretins and cardiovascular disease: to the heart of type 2 diabetes?

Anna Solini, Domenico Trico, Stefano Del Prato

Summary: Major cardiovascular outcome trials and real-life observations have shown that GLP-1 receptor agonists (GLP-1RAs) provide clinically relevant cardiovascular protection regardless of GLP-1 homology. GLP-1RAs offer cardioprotective benefits through various mechanisms, including improved insulin secretion and action, weight loss, reduced blood pressure, improved lipid profile, as well as direct effects on the heart and vasculature. The available evidence has led professional and medical societies to recommend GLP-1RAs for reducing cardiovascular risk in people with type 2 diabetes.

DIABETOLOGIA (2023)

Review Medicine, General & Internal

Renal Perfusion, Oxygenation and Metabolism: The Role of Imaging

Johanna Paivarinta, Ioanna A. A. Anastasiou, Niina Koivuviita, Kanishka Sharma, Pirjo Nuutila, Ele Ferrannini, Anna Solini, Eleni Rebelos

Summary: Thanks to medical imaging technology, the study of renal anatomy and physiology has advanced. However, difficulties in studying the metabolism and vasculature of the human kidney have limited research in these areas. This review provides an overview of recent findings on renal perfusion, oxygenation, and substrate uptake. The use of PET and fMRI has allowed for the evaluation of renal perfusion and the effects of therapeutic agents on kidney hemodynamics. Despite limited studies, these imaging modalities offer promising prospects for understanding renal pathophysiology in various diseases.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Cell Biology

Oral Delivery of mRNA Vaccine by Plant-Derived Extracellular Vesicle Carriers

Margherita A. C. Pomatto, Chiara Gai, Federica Negro, Lucia Massari, Maria Chiara Deregibus, Francesco Giuseppe De Rosa, Giovanni Camussi

Summary: Citrus sinensis-derived extracellular vesicles (oEVs) showed potential as carriers for oral mRNA vaccines, providing stability, optimal mucosal absorption, and immune response induction.
暂无数据